Cochrane Abstracts
Janus kinase inhibitors for the treatment of COVID‐19
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Janus Kinase Inhibitors for the Treatment of COVID‐19." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439404/all/Janus_kinase_inhibitors_for_the_treatment_of_COVID‐19.
Janus kinase inhibitors for the treatment of COVID‐19. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439404/all/Janus_kinase_inhibitors_for_the_treatment_of_COVID‐19. Accessed March 16, 2025.
Janus kinase inhibitors for the treatment of COVID‐19. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439404/all/Janus_kinase_inhibitors_for_the_treatment_of_COVID‐19
Janus Kinase Inhibitors for the Treatment of COVID‐19 [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439404/all/Janus_kinase_inhibitors_for_the_treatment_of_COVID‐19.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Janus kinase inhibitors for the treatment of COVID‐19
ID - 439404
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439404/all/Janus_kinase_inhibitors_for_the_treatment_of_COVID‐19
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
